SEC Form 6-K filed by British American Tobacco Industries p.l.c.

11/3/25 11:32:43 AM ET

$BTI

Medicinal Chemicals and Botanical Products

Health Care

Get the next $BTI alert in real time by email

6-K 1 form6-k.htm REPORT OF FOREIGN PRIVATE ISSUER

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

November 3, 2025

Commission File Number: 001-38159

BRITISH AMERICAN TOBACCO P.L.C.

(Translation of registrant’s name into English)

Globe House

4 Temple Place

London WC2R 2PG

United Kingdom
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of the date indicated in the relevant exhibit description.

EXHIBIT INDEX

Exhibit		Description

Exhibit 1		Press Release entitled “Transaction in own shares” dated October 1, 2025.

Exhibit 2		Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Voting Rights and Capital” dated October 1, 2025.

Exhibit 3		Press Release entitled “Transaction in own shares” dated October 2, 2025.

Exhibit 4		Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated October 2, 2025.

Exhibit 5		Press Release entitled “Transaction in own shares” dated October 3, 2025.

Exhibit 6		Press Release entitled “Transaction in own shares” dated October 6, 2025.

Exhibit 7		Press Release entitled “Transaction in own shares” dated October 7, 2025.

Exhibit 8		Press Release entitled “Transaction in own shares” dated October 8, 2025.

Exhibit 9		Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Share Buyback Programme” dated October 9, 2025.

Exhibit 10		Press Release entitled “Transaction in own shares” dated October 9, 2025.

Exhibit 11		Press Release entitled “Transaction in own shares” dated October 10, 2025.

Exhibit 12		Press Release entitled “British American Tobacco p.l.c. – TR-1: Notification of major holdings” dated October 13, 2025.

Exhibit 13		Press Release entitled “British American Tobacco p.l.c. (the “Company” or “BAT”) – Board Change” dated October 14, 2025.

Exhibit 14		Press Release entitled “Transaction in own shares” dated October 14, 2025.

Exhibit 15		Press Release entitled “Transaction in own shares” dated October 15, 2025.

Exhibit 16		Press Release entitled “Transaction in own shares” dated October 16, 2025.

Exhibit 17		Press Release entitled “Transaction in own shares” dated October 17, 2025.

Exhibit 18		Press Release entitled “British American Tobacco p.l.c. – TR-1: Notification of major holdings” dated October 17, 2025.

Exhibit 19		Press Release entitled “Transaction in own shares” dated October 20, 2025.

Exhibit 20		Press Release entitled “Transaction in own shares” dated October 21, 2025.

Exhibit 21		Press Release entitled “British American Tobacco p.l.c. Announces Tender Offer for Euro-Denominated Perpetual Subordinated Fixed-To-Reset Rate Non-Call 5.25 Year Securities” dated October 21, 2025.

Exhibit 22		Press Release entitled “Transaction in own shares” dated October 22, 2025.

Exhibit 23		Press Release entitled “Transaction in own shares” dated October 23, 2025.

Exhibit 24		Press Release entitled “Transaction in own shares” dated October 24, 2025.

Exhibit 25		Press Release entitled “Transaction in own shares” dated October 27, 2025.

Exhibit 26		Press Release entitled “Transaction in own shares” dated October 28, 2025.

Exhibit 27		Press Release entitled “Publication of Prospectus” dated October 28, 2025.

Exhibit 28		Press Release entitled “Transaction in own shares” dated October 29, 2025.

Exhibit 29		Press Release entitled “British American Tobacco p.l.c. announces Final Results in respect of its Tender Offer for Euro-Denominated Perpetual Subordinated Fixed-To-Reset Rate Non-Call 5.25 Year Securities” dated October 29, 2025.

Exhibit 30		Press Release entitled “Transaction in own shares” dated October 30, 2025.

Exhibit 31		Press Release entitled “Transaction in own shares” dated October 31, 2025.

Exhibit 32		Press Release entitled “British American Tobacco p.l.c. €1,000,000,000 Perpetual Subordinated Fixed-to-Reset Rate Non-Call 5.25 Year Securities (ISIN: XS2391779134; Common Code: 239177913) (the “Securities”)” dated October 31, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

British American Tobacco p.l.c.


By:	/s/ Christopher Worlock
	Name:	Christopher Worlock
	Title:	Assistant Secretary

Date: November 3, 2025

Get the next $BTI alert in real time by email

Recent Analyst Ratings for

$BTI

Date	Price Target	Rating	Analyst
9/8/2025	$62.00	Hold → Buy	Argus
9/2/2025		Sector Perform → Underperform	RBC Capital Mkts
7/9/2025		Buy	Jefferies
4/30/2025		Buy	BofA Securities
1/27/2025		Neutral → Buy	UBS
10/3/2024	$33.00	Overweight → Underweight	Morgan Stanley
1/23/2024		Neutral	UBS
11/1/2023	$38.00	Overweight	Morgan Stanley

More analyst ratings

SEC Form 6-K filed by British American Tobacco Industries p.l.c.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$BTI

SEC Form 6-K filed by British American Tobacco Industries p.l.c.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$BTI

$BTI
Analyst Ratings

British American Tobacco upgraded by Argus with a new price target

British American Tobacco downgraded by RBC Capital Mkts

Jefferies resumed coverage on British American Tobacco

$BTI
SEC Filings